Search 

UK based VC investing in life-sciences technology, tools and drug platforms. Other areas of interest include digital therapeutics.

MSA manages over $1.5 billion and invests in global leading early and growth-stage technology-enabled companies.

VC focused on healthcare industry

Private investment firm

Phoenix wealth provides access to investors to invest into siruptive technology during pre-seed or seed stages.

About Rius Medical: Rius Medical is designing and developing a new generation of Commercial cell therapies positioned at the crossroads of two high-potential programs: (1.) genetically engineering red blood cells for an entirely new class of cellular medicines and (2.) potent NK-cell therapy products. Due to their mechanism of action, engineered red blood cells demonstrated treatments for wide range of patients from starving cancer cells to targeting autoimmune diseases. Building on exceptional progress in cell therapies, Rius Medical is in a unique position to offer Third-Generation red blood cells for drug delivery that addresses Rare Diseases, Oncology and Autoimmune Diseases like type 1 diabetes! Furthermore, harnessing the unique power of natural killer (NK) cells enables the treatment of cancer and infectious diseases such as Influenza virus or SARS-Coronavirus (i.e. COVID-19 pandemic). That’s right, NK-cells as vaccine delivery NOT for antibodies but for “memory T cells” activation!

We are a group of angels selecting top companies to invest.

-

simcere pharmaceutical group